Myanmar offers incentives to lure its drug distributors into production

Myanmar has only a few companies making drugs for the country, leaving it to import more than 80% of its meds. Now the government is offering incentives to private distributors to coax them to move into production. Still, some industry people are concerned that the country is developing faster than companies' capacities to provide needed medications, which could leave Myanmar with a shortage if international aid dries up. More from FiercePharmaAsia

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.